Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Biomarkers of metabolic and mitochondrial function" is a broad descriptive term for various molecules and measurable features in biological fluids (like blood, urine, CSF) that indicate the status of mitochondrial health or metabolic function. These are not molecular targets for drugs, but rather diagnostic tools used to detect, monitor, and stratify diseases related to mitochondrial dysfunction and abnormal metabolism. Commonly studied biomarkers include lactate, pyruvate, FGF-21, and GDF-15, though many others exist. These markers can help support diagnosis (often in concert with genetic or imaging studies), inform prognosis, and track disease status in metabolic and mitochondrial diseases. However, many are not specific and require further validation for widespread clinical use[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biomarkers of metabolic and mitochondrial function.